Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
A recent online survey presented seven hypothetical, blinded drug profiles to 553 respondents in order to evaluate patient preferences towards various oral glucose-lowering therapies
Study medications, GLP-1 RAs, dipeptidyl peptidase 4 inhibitors and pramlintide were not allowed as rescue medications
Abd-Allah, A
Theyre both approved to treat type 2 diabetes, and each have twin medicines approved for weight loss
Confirm ongoing care-team access
US$ 20.09
US$ 26.90
US$ 27.23
US$ 25.52
US$ 29.73
US$ 22.11
US$ 26.58
US$ 22.81
US$ 25.09
US$ 28.14
US$ 28.10
US$ 24.79
US$ 25.41
US$ 25.29
